

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | daunorubicin metabolic process (GO:0044597) | 6.70356909 |
| 2 | polyketide metabolic process (GO:0030638) | 6.70356909 |
| 3 | doxorubicin metabolic process (GO:0044598) | 6.70356909 |
| 4 | response to pheromone (GO:0019236) | 6.23510625 |
| 5 | nucleotide transmembrane transport (GO:1901679) | 4.96445406 |
| 6 | proline transport (GO:0015824) | 4.25260871 |
| 7 | potassium ion export (GO:0071435) | 4.23200456 |
| 8 | detection of calcium ion (GO:0005513) | 4.18260181 |
| 9 | regulation of type B pancreatic cell apoptotic process (GO:2000674) | 4.03476727 |
| 10 | aminoglycoside antibiotic metabolic process (GO:0030647) | 4.03269467 |
| 11 | positive regulation of gamma-delta T cell activation (GO:0046645) | 3.93913912 |
| 12 | endocrine pancreas development (GO:0031018) | 3.92170667 |
| 13 | negative regulation of meiosis (GO:0045835) | 3.88225248 |
| 14 | type B pancreatic cell development (GO:0003323) | 3.86936811 |
| 15 | positive regulation of action potential (GO:0045760) | 3.85392317 |
| 16 | insulin secretion (GO:0030073) | 3.80291381 |
| 17 | inositol phosphate catabolic process (GO:0071545) | 3.76294406 |
| 18 | negative regulation of norepinephrine secretion (GO:0010700) | 3.74087649 |
| 19 | righting reflex (GO:0060013) | 3.64266808 |
| 20 | prostate gland growth (GO:0060736) | 3.61020369 |
| 21 | synaptic vesicle maturation (GO:0016188) | 3.60478826 |
| 22 | regulation of uterine smooth muscle contraction (GO:0070472) | 3.59753901 |
| 23 | cellular extravasation (GO:0045123) | 3.58625864 |
| 24 | drinking behavior (GO:0042756) | 3.49907611 |
| 25 | adaptation of signaling pathway (GO:0023058) | 3.44133514 |
| 26 | energy homeostasis (GO:0097009) | 3.40770062 |
| 27 | histone H3-K4 trimethylation (GO:0080182) | 3.37314180 |
| 28 | negative regulation of calcium ion-dependent exocytosis (GO:0045955) | 3.34748324 |
| 29 | positive regulation of protein sumoylation (GO:0033235) | 3.34199621 |
| 30 | glandular epithelial cell development (GO:0002068) | 3.33123370 |
| 31 | phosphorylated carbohydrate dephosphorylation (GO:0046838) | 3.31221856 |
| 32 | inositol phosphate dephosphorylation (GO:0046855) | 3.31221856 |
| 33 | behavioral response to ethanol (GO:0048149) | 3.27851814 |
| 34 | regulation of gamma-delta T cell activation (GO:0046643) | 3.26707019 |
| 35 | peptide hormone processing (GO:0016486) | 3.25231659 |
| 36 | glandular epithelial cell differentiation (GO:0002067) | 3.23453201 |
| 37 | protein targeting to Golgi (GO:0000042) | 3.22969249 |
| 38 | regulation of B cell receptor signaling pathway (GO:0050855) | 3.22744028 |
| 39 | establishment of protein localization to Golgi (GO:0072600) | 3.18743556 |
| 40 | positive regulation of synaptic transmission, dopaminergic (GO:0032226) | 3.16991699 |
| 41 | positive regulation of glycolytic process (GO:0045821) | 3.15825005 |
| 42 | negative regulation of catecholamine secretion (GO:0033604) | 3.10114628 |
| 43 | nucleotide transport (GO:0006862) | 3.10093405 |
| 44 | auditory receptor cell stereocilium organization (GO:0060088) | 3.07945745 |
| 45 | sulfate transmembrane transport (GO:1902358) | 3.06514768 |
| 46 | signal peptide processing (GO:0006465) | 3.05306187 |
| 47 | negative regulation of interleukin-17 production (GO:0032700) | 3.03310396 |
| 48 | presynaptic membrane assembly (GO:0097105) | 3.02638119 |
| 49 | response to peptidoglycan (GO:0032494) | 2.98998993 |
| 50 | detection of molecule of bacterial origin (GO:0032490) | 2.98480639 |
| 51 | protein localization to Golgi apparatus (GO:0034067) | 2.96170548 |
| 52 | retrograde transport, vesicle recycling within Golgi (GO:0000301) | 2.95011965 |
| 53 | negative regulation of meiotic cell cycle (GO:0051447) | 2.89263437 |
| 54 | regulation of gamma-delta T cell differentiation (GO:0045586) | 2.88521357 |
| 55 | neurological system process involved in regulation of systemic arterial blood pressure (GO:0001976) | 2.87752471 |
| 56 | cellular response to ethanol (GO:0071361) | 2.85176392 |
| 57 | alanine transport (GO:0032328) | 2.81660909 |
| 58 | regulation of hexokinase activity (GO:1903299) | 2.80003358 |
| 59 | regulation of glucokinase activity (GO:0033131) | 2.80003358 |
| 60 | negative regulation of synaptic transmission, GABAergic (GO:0032229) | 2.79098799 |
| 61 | ER overload response (GO:0006983) | 2.79038102 |
| 62 | positive regulation of toll-like receptor signaling pathway (GO:0034123) | 2.77105395 |
| 63 | positive regulation of fibroblast migration (GO:0010763) | 2.76562604 |
| 64 | sulfate transport (GO:0008272) | 2.75809182 |
| 65 | regulation of synaptic vesicle transport (GO:1902803) | 2.73645569 |
| 66 | inner ear receptor stereocilium organization (GO:0060122) | 2.72859632 |
| 67 | nitric oxide mediated signal transduction (GO:0007263) | 2.72371157 |
| 68 | dentate gyrus development (GO:0021542) | 2.71591178 |
| 69 | polyol catabolic process (GO:0046174) | 2.71022791 |
| 70 | regulation of meiosis (GO:0040020) | 2.70504992 |
| 71 | cellular response to interleukin-15 (GO:0071350) | 2.69206877 |
| 72 | postsynaptic membrane organization (GO:0001941) | 2.68968862 |
| 73 | positive regulation of histone H3-K4 methylation (GO:0051571) | 2.67562461 |
| 74 | mesenchymal cell differentiation involved in kidney development (GO:0072161) | 2.67506551 |
| 75 | mesenchymal cell differentiation involved in renal system development (GO:2001012) | 2.67506551 |
| 76 | peptide hormone secretion (GO:0030072) | 2.67233783 |
| 77 | regulation of calcineurin-NFAT signaling cascade (GO:0070884) | 2.66940832 |
| 78 | opioid receptor signaling pathway (GO:0038003) | 2.66461451 |
| 79 | regulation of phosphoprotein phosphatase activity (GO:0043666) | 2.65717007 |
| 80 | Golgi transport vesicle coating (GO:0048200) | 2.63998415 |
| 81 | COPI coating of Golgi vesicle (GO:0048205) | 2.63998415 |
| 82 | interleukin-1-mediated signaling pathway (GO:0070498) | 2.63307819 |
| 83 | regulation of mast cell activation (GO:0033003) | 2.63267040 |
| 84 | membrane repolarization during action potential (GO:0086011) | 2.61178683 |
| 85 | regulation of short-term neuronal synaptic plasticity (GO:0048172) | 2.61091376 |
| 86 | mannose metabolic process (GO:0006013) | 2.60905691 |
| 87 | eosinophil chemotaxis (GO:0048245) | 2.59861871 |
| 88 | adult feeding behavior (GO:0008343) | 2.59592378 |
| 89 | negative regulation of exocytosis (GO:0045920) | 2.59075827 |
| 90 | urinary tract smooth muscle contraction (GO:0014848) | 2.58901480 |
| 91 | detection of chemical stimulus (GO:0009593) | 2.56738362 |
| 92 | positive regulation of B cell differentiation (GO:0045579) | 2.55960960 |
| 93 | peptide secretion (GO:0002790) | 2.55741684 |
| 94 | metanephric mesenchyme development (GO:0072075) | 2.54581677 |
| 95 | regulation of insulin secretion (GO:0050796) | 2.54158089 |
| 96 | B cell receptor signaling pathway (GO:0050853) | 2.54118269 |
| 97 | regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway (GO:1902235 | 2.53369787 |
| 98 | regulation of synaptic vesicle exocytosis (GO:2000300) | 2.52949529 |
| 99 | interleukin-6-mediated signaling pathway (GO:0070102) | 2.52555164 |
| 100 | positive regulation of synaptic transmission, GABAergic (GO:0032230) | 2.52048722 |
| 101 | regulation of timing of cell differentiation (GO:0048505) | 2.51129301 |
| 102 | regulation of action potential (GO:0098900) | 2.51112730 |
| 103 | behavioral response to nicotine (GO:0035095) | 2.50995341 |
| 104 | ganglion development (GO:0061548) | 2.50752964 |
| 105 | regulation of synaptic transmission, GABAergic (GO:0032228) | 2.50423966 |
| 106 | pancreas development (GO:0031016) | 2.49962813 |
| 107 | developmental pigmentation (GO:0048066) | 2.49874331 |
| 108 | columnar/cuboidal epithelial cell development (GO:0002066) | 2.49843651 |
| 109 | regulation of meiotic cell cycle (GO:0051445) | 2.48805917 |
| 110 | regulation of mast cell degranulation (GO:0043304) | 2.47727470 |
| 111 | negative regulation of synaptic transmission, glutamatergic (GO:0051967) | 2.47264633 |
| 112 | presynaptic membrane organization (GO:0097090) | 2.45844635 |
| 113 | response to interleukin-15 (GO:0070672) | 2.44062567 |
| 114 | positive regulation of mast cell activation (GO:0033005) | 2.43918967 |
| 115 | signal transduction involved in regulation of gene expression (GO:0023019) | 2.43314359 |
| 116 | negative regulation of cAMP-mediated signaling (GO:0043951) | 2.43292583 |
| 117 | regulation of mast cell activation involved in immune response (GO:0033006) | 2.43062312 |
| 118 | negative regulation of interleukin-12 production (GO:0032695) | 2.42220355 |
| 119 | detection of external biotic stimulus (GO:0098581) | 2.42074225 |
| 120 | macrophage activation involved in immune response (GO:0002281) | 2.38889542 |
| 121 | pharyngeal system development (GO:0060037) | 2.37990842 |
| 122 | protein K11-linked deubiquitination (GO:0035871) | 2.37786991 |
| 123 | interferon-gamma production (GO:0032609) | 2.37668067 |
| 124 | phagosome maturation (GO:0090382) | 2.37134255 |
| 125 | serotonin metabolic process (GO:0042428) | 2.37025606 |
| 126 | positive regulation of CREB transcription factor activity (GO:0032793) | 2.37021842 |
| 127 | pigment granule localization (GO:0051875) | 2.36464086 |
| 128 | regulation of germinal center formation (GO:0002634) | 2.35941720 |
| 129 | response to muramyl dipeptide (GO:0032495) | 2.35941709 |
| 130 | startle response (GO:0001964) | 2.35838191 |
| 131 | natural killer cell activation involved in immune response (GO:0002323) | 2.35491054 |
| 132 | negative regulation of keratinocyte proliferation (GO:0010839) | 2.35349759 |
| 133 | regulation of N-methyl-D-aspartate selective glutamate receptor activity (GO:2000310) | 2.34960014 |
| 134 | regulation of norepinephrine secretion (GO:0014061) | 2.34696340 |
| 135 | regulation of peptide hormone secretion (GO:0090276) | 2.34115756 |
| 136 | positive regulation of phosphoprotein phosphatase activity (GO:0032516) | 2.34062173 |
| 137 | regulation of calcium ion-dependent exocytosis (GO:0017158) | 2.33915491 |
| 138 | cellular response to pH (GO:0071467) | 2.33037118 |
| 139 | activated T cell proliferation (GO:0050798) | 2.32367799 |
| 140 | synaptic vesicle endocytosis (GO:0048488) | 2.32071528 |
| 141 | cyclic nucleotide catabolic process (GO:0009214) | 2.32032160 |
| 142 | regulation of natural killer cell mediated cytotoxicity (GO:0042269) | 2.31417426 |
| 143 | regulation of natural killer cell mediated immunity (GO:0002715) | 2.31417426 |
| 144 | glycoside metabolic process (GO:0016137) | 2.31388581 |
| 145 | regulation of peptide secretion (GO:0002791) | 2.31150965 |
| 146 | cellular anion homeostasis (GO:0030002) | 2.31107643 |
| 147 | regulation of protein sumoylation (GO:0033233) | 2.31002488 |
| 148 | negative regulation of T cell mediated immunity (GO:0002710) | 2.30513753 |
| 149 | cornea development in camera-type eye (GO:0061303) | 2.30135404 |
| 150 | retrograde vesicle-mediated transport, Golgi to ER (GO:0006890) | 2.29851406 |
| 151 | positive regulation of uterine smooth muscle contraction (GO:0070474) | 2.29829109 |
| 152 | hormone secretion (GO:0046879) | 2.29744478 |
| 153 | negative regulation of cell killing (GO:0031342) | 2.29545967 |
| 154 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 2.29545967 |
| 155 | regulation of autophagic vacuole assembly (GO:2000785) | 2.26181211 |
| 156 | tolerance induction (GO:0002507) | 2.26041476 |
| 157 | neutrophil activation involved in immune response (GO:0002283) | 2.25684707 |
| 158 | negative regulation of growth of symbiont in host (GO:0044130) | 2.23762166 |
| 159 | negative regulation of growth of symbiont involved in interaction with host (GO:0044146) | 2.23762166 |
| 160 | modulation of growth of symbiont involved in interaction with host (GO:0044144) | 2.23762166 |
| 161 | regulation of growth of symbiont in host (GO:0044126) | 2.23762166 |
| 162 | positive regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043372) | 2.23524796 |
| 163 | actin filament polymerization (GO:0030041) | 2.21602391 |
| 164 | production of molecular mediator involved in inflammatory response (GO:0002532) | 2.20219522 |
| 165 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 2.19577538 |
| 166 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 2.19577538 |
| 167 | modulation by symbiont of host immune response (GO:0052553) | 2.19577538 |
| 168 | positive regulation by symbiont of host defense response (GO:0052509) | 2.19577538 |
| 169 | modulation by symbiont of host defense response (GO:0052031) | 2.19577538 |
| 170 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 2.19577538 |
| 171 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 2.19052004 |
| 172 | response to host immune response (GO:0052572) | 2.19052004 |
| 173 | epithelial cell fate commitment (GO:0072148) | 2.18337764 |
| 174 | negative regulation of CD4-positive, alpha-beta T cell activation (GO:2000515) | 2.17856801 |
| 175 | valine metabolic process (GO:0006573) | 2.15837232 |
| 176 | peptidyl-lysine trimethylation (GO:0018023) | 2.15040736 |
| 177 | glucosamine-containing compound catabolic process (GO:1901072) | 2.14874461 |
| 178 | regulation of oxidative phosphorylation (GO:0002082) | 2.14695925 |
| 179 | Peyers patch development (GO:0048541) | 2.13587619 |
| 180 | mucosal-associated lymphoid tissue development (GO:0048537) | 2.13587619 |
| 181 | nerve growth factor signaling pathway (GO:0038180) | 2.13180198 |
| 182 | regulation of B cell differentiation (GO:0045577) | 2.13002324 |
| 183 | negative regulation of lymphocyte mediated immunity (GO:0002707) | 2.11097887 |
| 184 | positive regulation of mast cell degranulation (GO:0043306) | 2.10956906 |
| 185 | positive regulation of mast cell activation involved in immune response (GO:0033008) | 2.10956906 |
| 186 | negative regulation of alpha-beta T cell activation (GO:0046636) | 2.09924751 |
| 187 | positive regulation of digestive system process (GO:0060456) | 2.09364255 |
| 188 | regulation of memory T cell differentiation (GO:0043380) | 2.09319241 |
| 189 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 2.06643970 |
| 190 | mast cell activation (GO:0045576) | 2.05388450 |
| 191 | regulation of ventricular cardiac muscle cell membrane repolarization (GO:0060307) | 2.04161091 |
| 192 | positive regulation of CD4-positive, alpha-beta T cell activation (GO:2000516) | 2.03898013 |
| 193 | positive regulation of interleukin-12 production (GO:0032735) | 2.03876795 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | EZH2_22144423_ChIP-Seq_EOC_Human | 4.94781348 |
| 2 | GBX2_23144817_ChIP-Seq_PC3_Human | 4.13758233 |
| 3 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 4.12578317 |
| 4 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 2.62107046 |
| 5 | IGF1R_20145208_ChIP-Seq_DFB_Human | 2.54957272 |
| 6 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 2.53252300 |
| 7 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 2.51069556 |
| 8 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 2.45186134 |
| 9 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 2.42280374 |
| 10 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 2.41994175 |
| 11 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 2.30339123 |
| 12 | BMI1_23680149_ChIP-Seq_NPCS_Mouse | 2.23724440 |
| 13 | GATA1_22025678_ChIP-Seq_K562_Human | 2.18364590 |
| 14 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 2.10173339 |
| 15 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 2.06900168 |
| 16 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 1.99405119 |
| 17 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.97133238 |
| 18 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.96968632 |
| 19 | P300_19829295_ChIP-Seq_ESCs_Human | 1.95696292 |
| 20 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 1.93500517 |
| 21 | SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 1.90521716 |
| 22 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 1.88471780 |
| 23 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 1.87029207 |
| 24 | NANOG_18555785_Chip-Seq_ESCs_Mouse | 1.85773244 |
| 25 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 1.85195845 |
| 26 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 1.83696584 |
| 27 | SUZ12_27294783_Chip-Seq_NPCs_Mouse | 1.83064354 |
| 28 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 1.79027154 |
| 29 | SPI1_23127762_ChIP-Seq_K562_Human | 1.78407053 |
| 30 | TCFCP2L1_18555785_Chip-Seq_ESCs_Mouse | 1.77430675 |
| 31 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 1.76990996 |
| 32 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.76697351 |
| 33 | SMAD4_21799915_ChIP-Seq_A2780_Human | 1.76227411 |
| 34 | REST_21632747_ChIP-Seq_MESCs_Mouse | 1.73885151 |
| 35 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 1.71964602 |
| 36 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 1.69527981 |
| 37 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.69009994 |
| 38 | EBF1_22473956_ChIP-Seq_BONE_MARROW_Mouse | 1.68548893 |
| 39 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 1.67641877 |
| 40 | MEIS1_26253404_ChIP-Seq_OPTIC_CUPS_Mouse | 1.67074433 |
| 41 | CBX2_27304074_Chip-Seq_ESCs_Mouse | 1.66680229 |
| 42 | NFE2_27457419_Chip-Seq_LIVER_Mouse | 1.66615541 |
| 43 | RNF2_27304074_Chip-Seq_NSC_Mouse | 1.65963303 |
| 44 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 1.65513730 |
| 45 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 1.64621715 |
| 46 | VDR_22108803_ChIP-Seq_LS180_Human | 1.64425127 |
| 47 | P53_22387025_ChIP-Seq_ESCs_Mouse | 1.63345084 |
| 48 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.63234051 |
| 49 | STAT3_23295773_ChIP-Seq_U87_Human | 1.63189211 |
| 50 | STAT3_18555785_Chip-Seq_ESCs_Mouse | 1.62749766 |
| 51 | E2F1_18555785_Chip-Seq_ESCs_Mouse | 1.62411917 |
| 52 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.62157490 |
| 53 | CDKN2AIP_20523734_ChIP-Seq_CORTICAL_Neurons | 1.60771331 |
| 54 | PCGF2_27294783_Chip-Seq_NPCs_Mouse | 1.59767601 |
| 55 | SUZ12_18555785_Chip-Seq_ESCs_Mouse | 1.58552132 |
| 56 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 1.57250841 |
| 57 | SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 1.52006675 |
| 58 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 1.51143057 |
| 59 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 1.51143057 |
| 60 | RUNX_20019798_ChIP-Seq_JUKART_Human | 1.51027693 |
| 61 | EZH2_27294783_Chip-Seq_NPCs_Mouse | 1.50560461 |
| 62 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 1.50517441 |
| 63 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 1.50416439 |
| 64 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.50243243 |
| 65 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 1.49444933 |
| 66 | NMYC_18555785_Chip-Seq_ESCs_Mouse | 1.49233750 |
| 67 | * EZH2_27294783_Chip-Seq_ESCs_Mouse | 1.49125455 |
| 68 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 1.48623576 |
| 69 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 1.48374355 |
| 70 | CEBPB_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.45837991 |
| 71 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.45678100 |
| 72 | CMYC_18555785_Chip-Seq_ESCs_Mouse | 1.45444069 |
| 73 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 1.44947928 |
| 74 | SOX2_18555785_Chip-Seq_ESCs_Mouse | 1.44109181 |
| 75 | TCF4_23295773_ChIP-Seq_U87_Human | 1.43973021 |
| 76 | SUZ12_27294783_Chip-Seq_ESCs_Mouse | 1.43107192 |
| 77 | RNF2_27304074_Chip-Seq_ESCs_Mouse | 1.42997791 |
| 78 | AR_25329375_ChIP-Seq_VCAP_Human | 1.42572745 |
| 79 | AR_21572438_ChIP-Seq_LNCaP_Human | 1.40926615 |
| 80 | ZNF274_21170338_ChIP-Seq_K562_Hela | 1.40594159 |
| 81 | FUS_26573619_Chip-Seq_HEK293_Human | 1.40286032 |
| 82 | VDR_20736230_ChIP-Seq_LYMPHOBLASTOID_Human | 1.40279068 |
| 83 | P300_18555785_Chip-Seq_ESCs_Mouse | 1.40038900 |
| 84 | EBF1_22473956_ChIP-Seq_LYMPHODE_Mouse | 1.38027777 |
| 85 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 1.36396641 |
| 86 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 1.36130988 |
| 87 | SMAD3_21741376_ChIP-Seq_EPCs_Human | 1.35612917 |
| 88 | ER_23166858_ChIP-Seq_MCF-7_Human | 1.33550304 |
| 89 | MTF2_20144788_ChIP-Seq_MESCs_Mouse | 1.32413117 |
| 90 | ZFX_18555785_Chip-Seq_ESCs_Mouse | 1.32228900 |
| 91 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 1.31846005 |
| 92 | DROSHA_22980978_ChIP-Seq_HELA_Human | 1.31520049 |
| 93 | TOP2B_26459242_ChIP-Seq_MCF-7_Human | 1.31450048 |
| 94 | OCT4_18555785_Chip-Seq_ESCs_Mouse | 1.31150630 |
| 95 | RUNX1_27457419_Chip-Seq_LIVER_Mouse | 1.30891863 |
| 96 | GATA3_26560356_Chip-Seq_TH2_Human | 1.30427199 |
| 97 | ESRRB_18555785_Chip-Seq_ESCs_Mouse | 1.29869698 |
| 98 | GATA3_27048872_Chip-Seq_THYMUS_Human | 1.29426951 |
| 99 | KLF4_18555785_Chip-Seq_ESCs_Mouse | 1.28663430 |
| 100 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.28583793 |
| 101 | CTCF_18555785_Chip-Seq_ESCs_Mouse | 1.27285126 |
| 102 | SPI1_23547873_ChIP-Seq_NB4_Human | 1.26341023 |
| 103 | TAF15_26573619_Chip-Seq_HEK293_Human | 1.25645908 |
| 104 | RNF2_16625203_ChIP-ChIP_MESCs_Mouse | 1.25368041 |
| 105 | EWS_26573619_Chip-Seq_HEK293_Human | 1.24678601 |
| 106 | CBP_20019798_ChIP-Seq_JUKART_Human | 1.24111317 |
| 107 | IRF4_20064451_ChIP-Seq_CD4+T_Mouse | 1.24111317 |
| 108 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 1.23627449 |
| 109 | PU1_27457419_Chip-Seq_LIVER_Mouse | 1.22386010 |
| 110 | POU5F1_26923725_Chip-Seq_MESODERM_Mouse | 1.21882479 |
| 111 | TEAD4_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.21882479 |
| 112 | BCAT_22108803_ChIP-Seq_LS180_Human | 1.21327297 |
| 113 | TAL1_26923725_Chip-Seq_HPCs_Mouse | 1.21108130 |
| 114 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 1.21056920 |
| 115 | RCOR2_21632747_ChIP-Seq_MESCs_Mouse | 1.20497760 |
| 116 | OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.19913445 |
| 117 | SMAD1_18555785_Chip-Seq_ESCs_Mouse | 1.19789346 |
| 118 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 1.19625085 |
| 119 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.18397940 |
| 120 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 1.18356528 |
| 121 | NR3C1_21868756_ChIP-Seq_MCF10A_Human | 1.17642695 |
| 122 | ZFP322A_24550733_ChIP-Seq_MESCs_Mouse | 1.17291889 |
| 123 | TEAD4_22529382_ChIP-Seq_TROPHECTODERM_Mouse | 1.16976715 |
| 124 | * RUNX2_22187159_ChIP-Seq_PCA_Human | 1.16731091 |
| 125 | MYB_26560356_Chip-Seq_TH2_Human | 1.16515718 |
| 126 | KDM2B_26808549_Chip-Seq_REH_Human | 1.16012503 |
| 127 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 1.15731019 |
| 128 | PHC1_16625203_ChIP-ChIP_MESCs_Mouse | 1.14960104 |
| 129 | CDX2_21402776_ChIP-Seq_INTESTINAL-VILLUS_Mouse | 1.14533486 |
| 130 | PRDM14_20953172_ChIP-Seq_ESCs_Human | 1.14312542 |
| 131 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.13102884 |
| 132 | CEBPB_26923725_Chip-Seq_MESODERM_Mouse | 1.11839862 |
| 133 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 1.11655707 |
| 134 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 1.10813490 |
| 135 | SOX2_21211035_ChIP-Seq_LN229_Gbm | 1.07344317 |
| 136 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.07101340 |
| 137 | GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.06645862 |
| 138 | YAP1_20516196_ChIP-Seq_MESCs_Mouse | 1.06305885 |
| 139 | P53_22127205_ChIP-Seq_FIBROBLAST_Human | 1.05721834 |
| 140 | PBX1_22567123_ChIP-ChIP_OVCAR3_Human | 1.05359075 |
| 141 | REST_18959480_ChIP-ChIP_MESCs_Mouse | 1.04893181 |
| 142 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 1.02959187 |
| 143 | SMRT_27268052_Chip-Seq_Bcells_Human | 1.02215439 |
| 144 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.01424447 |
| 145 | SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 0.99484702 |
| 146 | SOX2_19829295_ChIP-Seq_ESCs_Human | 0.94657871 |
| 147 | NANOG_19829295_ChIP-Seq_ESCs_Human | 0.94657871 |
| 148 | SCL_19346495_ChIP-Seq_HPC-7_Human | 0.92746530 |
| 149 | TCF3/E2A_22897851_ChIP-Seq_JUKARTE6-1_Human | 0.92677449 |
| 150 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 0.92562323 |
| 151 | TBL1_22424771_ChIP-Seq_293T_Human | 0.92114805 |
| 152 | EWS-FLI1_20517297_ChIP-Seq_SK-N-MC_Human | 0.91603884 |
| 153 | UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 0.89065185 |
| 154 | WDR5_24793694_ChIP-Seq_LNCAP_Human | 0.88774638 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0010386_abnormal_urinary_bladder | 4.19094435 |
| 2 | MP0005645_abnormal_hypothalamus_physiol | 4.09085762 |
| 3 | MP0005646_abnormal_pituitary_gland | 3.80494160 |
| 4 | MP0003183_abnormal_peptide_metabolism | 3.29129601 |
| 5 | MP0006292_abnormal_olfactory_placode | 3.21949337 |
| 6 | MP0005379_endocrine/exocrine_gland_phen | 2.96542792 |
| 7 | MP0004043_abnormal_pH_regulation | 2.88303186 |
| 8 | MP0005671_abnormal_response_to | 2.83018714 |
| 9 | MP0001188_hyperpigmentation | 2.81948501 |
| 10 | MP0002638_abnormal_pupillary_reflex | 2.71416269 |
| 11 | MP0001986_abnormal_taste_sensitivity | 2.70517414 |
| 12 | MP0001835_abnormal_antigen_presentation | 2.61423511 |
| 13 | MP0000678_abnormal_parathyroid_gland | 2.56980446 |
| 14 | MP0009780_abnormal_chondrocyte_physiolo | 2.49295586 |
| 15 | MP0002876_abnormal_thyroid_physiology | 2.47977315 |
| 16 | MP0003724_increased_susceptibility_to | 2.31100489 |
| 17 | MP0006276_abnormal_autonomic_nervous | 2.29311279 |
| 18 | MP0003787_abnormal_imprinting | 2.28777971 |
| 19 | MP0000566_synostosis | 2.27329262 |
| 20 | MP0002877_abnormal_melanocyte_morpholog | 2.27113566 |
| 21 | MP0003303_peritoneal_inflammation | 2.23246848 |
| 22 | MP0002254_reproductive_system_inflammat | 2.20012566 |
| 23 | MP0000685_abnormal_immune_system | 2.18672345 |
| 24 | MP0002693_abnormal_pancreas_physiology | 2.17827469 |
| 25 | MP0005387_immune_system_phenotype | 2.15256790 |
| 26 | MP0001790_abnormal_immune_system | 2.15256790 |
| 27 | MP0003879_abnormal_hair_cell | 2.11985752 |
| 28 | MP0002163_abnormal_gland_morphology | 2.06667774 |
| 29 | MP0009785_altered_susceptibility_to | 1.98200675 |
| 30 | MP0008004_abnormal_stomach_pH | 1.92728323 |
| 31 | MP0003122_maternal_imprinting | 1.88897814 |
| 32 | MP0009697_abnormal_copulation | 1.88549183 |
| 33 | MP0001944_abnormal_pancreas_morphology | 1.84860113 |
| 34 | MP0006072_abnormal_retinal_apoptosis | 1.84601800 |
| 35 | MP0005000_abnormal_immune_tolerance | 1.82113450 |
| 36 | MP0002419_abnormal_innate_immunity | 1.79582256 |
| 37 | MP0001800_abnormal_humoral_immune | 1.73597805 |
| 38 | MP0002277_abnormal_respiratory_mucosa | 1.73537296 |
| 39 | MP0000631_abnormal_neuroendocrine_gland | 1.72937912 |
| 40 | MP0000013_abnormal_adipose_tissue | 1.70859587 |
| 41 | MP0003656_abnormal_erythrocyte_physiolo | 1.68523354 |
| 42 | MP0003283_abnormal_digestive_organ | 1.66355289 |
| 43 | MP0006082_CNS_inflammation | 1.64933328 |
| 44 | MP0003436_decreased_susceptibility_to | 1.64606958 |
| 45 | MP0002837_dystrophic_cardiac_calcinosis | 1.61169596 |
| 46 | MP0002723_abnormal_immune_serum | 1.61062167 |
| 47 | MP0001502_abnormal_circadian_rhythm | 1.60239663 |
| 48 | MP0002452_abnormal_antigen_presenting | 1.56049767 |
| 49 | MP0005257_abnormal_intraocular_pressure | 1.55704206 |
| 50 | MP0005025_abnormal_response_to | 1.54607597 |
| 51 | MP0002420_abnormal_adaptive_immunity | 1.52786605 |
| 52 | MP0001501_abnormal_sleep_pattern | 1.51890937 |
| 53 | MP0002148_abnormal_hypersensitivity_rea | 1.50691936 |
| 54 | MP0001819_abnormal_immune_cell | 1.49092626 |
| 55 | MP0000681_abnormal_thyroid_gland | 1.46569089 |
| 56 | MP0002572_abnormal_emotion/affect_behav | 1.44102210 |
| 57 | MP0005220_abnormal_exocrine_pancreas | 1.42602249 |
| 58 | MP0002909_abnormal_adrenal_gland | 1.40877262 |
| 59 | MP0002132_abnormal_respiratory_system | 1.40653442 |
| 60 | MP0003045_fibrosis | 1.36908635 |
| 61 | MP0003195_calcinosis | 1.36730034 |
| 62 | MP0000015_abnormal_ear_pigmentation | 1.36696518 |
| 63 | MP0002557_abnormal_social/conspecific_i | 1.35119747 |
| 64 | MP0001529_abnormal_vocalization | 1.34407474 |
| 65 | MP0003121_genomic_imprinting | 1.33520569 |
| 66 | MP0001486_abnormal_startle_reflex | 1.30691521 |
| 67 | MP0003635_abnormal_synaptic_transmissio | 1.29983626 |
| 68 | MP0002734_abnormal_mechanical_nocicepti | 1.28289533 |
| 69 | MP0000538_abnormal_urinary_bladder | 1.28213956 |
| 70 | MP0002735_abnormal_chemical_nociception | 1.25895193 |
| 71 | MP0003868_abnormal_feces_composition | 1.23641751 |
| 72 | MP0001485_abnormal_pinna_reflex | 1.23589493 |
| 73 | MP0004147_increased_porphyrin_level | 1.22740257 |
| 74 | MP0005171_absent_coat_pigmentation | 1.21386896 |
| 75 | MP0005423_abnormal_somatic_nervous | 1.20273270 |
| 76 | MP0009745_abnormal_behavioral_response | 1.19319049 |
| 77 | MP0005377_hearing/vestibular/ear_phenot | 1.19075876 |
| 78 | MP0003878_abnormal_ear_physiology | 1.19075876 |
| 79 | MP0003880_abnormal_central_pattern | 1.18641311 |
| 80 | MP0009840_abnormal_foam_cell | 1.16487128 |
| 81 | MP0005058_abnormal_lysosome_morphology | 1.16244156 |
| 82 | MP0002272_abnormal_nervous_system | 1.14266141 |
| 83 | MP0003763_abnormal_thymus_physiology | 1.14198908 |
| 84 | MP0001346_abnormal_lacrimal_gland | 1.13139582 |
| 85 | MP0005310_abnormal_salivary_gland | 1.11212333 |
| 86 | MP0001661_extended_life_span | 1.10745308 |
| 87 | MP0002063_abnormal_learning/memory/cond | 1.10314104 |
| 88 | MP0002405_respiratory_system_inflammati | 1.09961224 |
| 89 | MP0001533_abnormal_skeleton_physiology | 1.08134447 |
| 90 | MP0004484_altered_response_of | 1.07880403 |
| 91 | MP0005167_abnormal_blood-brain_barrier | 1.07620897 |
| 92 | MP0003300_gastrointestinal_ulcer | 1.05926095 |
| 93 | MP0000716_abnormal_immune_system | 1.05649183 |
| 94 | MP0001845_abnormal_inflammatory_respons | 1.04315525 |
| 95 | MP0001905_abnormal_dopamine_level | 1.03936741 |
| 96 | MP0000613_abnormal_salivary_gland | 1.03326878 |
| 97 | MP0004782_abnormal_surfactant_physiolog | 1.03295467 |
| 98 | MP0005451_abnormal_body_composition | 1.03150655 |
| 99 | MP0003690_abnormal_glial_cell | 1.02452458 |
| 100 | MP0004742_abnormal_vestibular_system | 1.01927912 |
| 101 | MP0005410_abnormal_fertilization | 1.01809270 |
| 102 | MP0003075_altered_response_to | 1.01590277 |
| 103 | MP0005409_darkened_coat_color | 1.00415990 |
| 104 | MP0002398_abnormal_bone_marrow | 1.00349454 |
| 105 | MP0000920_abnormal_myelination | 0.99970512 |
| 106 | MP0002078_abnormal_glucose_homeostasis | 0.99251228 |
| 107 | MP0002928_abnormal_bile_duct | 0.98689680 |
| 108 | MP0005670_abnormal_white_adipose | 0.97087547 |
| 109 | MP0003633_abnormal_nervous_system | 0.96805353 |
| 110 | MP0004885_abnormal_endolymph | 0.96795007 |
| 111 | MP0004381_abnormal_hair_follicle | 0.96541833 |
| 112 | MP0001963_abnormal_hearing_physiology | 0.96361030 |
| 113 | MP0002184_abnormal_innervation | 0.94608207 |
| 114 | MP0005253_abnormal_eye_physiology | 0.94276379 |
| 115 | MP0004270_analgesia | 0.94040003 |
| 116 | MP0008872_abnormal_physiological_respon | 0.93941169 |
| 117 | MP0004859_abnormal_synaptic_plasticity | 0.93219084 |
| 118 | MP0005389_reproductive_system_phenotype | 0.93039155 |
| 119 | MP0002064_seizures | 0.92984942 |
| 120 | MP0002938_white_spotting | 0.92573566 |
| 121 | MP0002177_abnormal_outer_ear | 0.92392075 |
| 122 | MP0001970_abnormal_pain_threshold | 0.92041188 |
| 123 | MP0008469_abnormal_protein_level | 0.91944421 |
| 124 | MP0001968_abnormal_touch/_nociception | 0.91322575 |
| 125 | MP0006036_abnormal_mitochondrial_physio | 0.91302647 |
| 126 | MP0000372_irregular_coat_pigmentation | 0.91006722 |
| 127 | MP0000689_abnormal_spleen_morphology | 0.90654580 |
| 128 | MP0005386_behavior/neurological_phenoty | 0.89792567 |
| 129 | MP0004924_abnormal_behavior | 0.89792567 |
| 130 | MP0002067_abnormal_sensory_capabilities | 0.89063044 |
| 131 | MP0002722_abnormal_immune_system | 0.88940216 |
| 132 | MP0008874_decreased_physiological_sensi | 0.88644065 |
| 133 | MP0009046_muscle_twitch | 0.88578718 |
| 134 | MP0005535_abnormal_body_temperature | 0.88570327 |
| 135 | MP0001919_abnormal_reproductive_system | 0.87488446 |
| 136 | MP0001765_abnormal_ion_homeostasis | 0.86915682 |
| 137 | MP0000569_abnormal_digit_pigmentation | 0.86696602 |
| 138 | MP0004264_abnormal_extraembryonic_tissu | 0.86666832 |
| 139 | MP0008877_abnormal_DNA_methylation | 0.85978671 |
| 140 | MP0002102_abnormal_ear_morphology | 0.85653174 |
| 141 | MP0003953_abnormal_hormone_level | 0.85269920 |
| 142 | MP0000026_abnormal_inner_ear | 0.85124482 |
| 143 | MP0002139_abnormal_hepatobiliary_system | 0.84129819 |
| 144 | MP0001440_abnormal_grooming_behavior | 0.84012223 |
| 145 | MP0001984_abnormal_olfaction | 0.83424931 |
| 146 | MP0001186_pigmentation_phenotype | 0.83371120 |
| 147 | MP0003828_pulmonary_edema | 0.83307985 |
| 148 | MP0004142_abnormal_muscle_tone | 0.82852796 |
| 149 | MP0008057_abnormal_DNA_replication | 0.82306893 |
| 150 | MP0005166_decreased_susceptibility_to | 0.81702454 |
| 151 | MP0005647_abnormal_sex_gland | 0.80309678 |
| 152 | MP0002160_abnormal_reproductive_system | 0.79452436 |
| 153 | MP0001664_abnormal_digestion | 0.79400520 |
| 154 | MP0000703_abnormal_thymus_morphology | 0.78337099 |
| 155 | MP0000343_altered_response_to | 0.78035966 |
| 156 | MP0009764_decreased_sensitivity_to | 0.77723289 |
| 157 | MP0002138_abnormal_hepatobiliary_system | 0.76641453 |
| 158 | MP0002733_abnormal_thermal_nociception | 0.75425802 |
| 159 | MP0001545_abnormal_hematopoietic_system | 0.74423362 |
| 160 | MP0005397_hematopoietic_system_phenotyp | 0.74423362 |
| 161 | MP0002229_neurodegeneration | 0.74422525 |
| 162 | MP0003172_abnormal_lysosome_physiology | 0.73776051 |
| 163 | MP0005551_abnormal_eye_electrophysiolog | 0.70762292 |
| 164 | MP0000049_abnormal_middle_ear | 0.66522277 |
| 165 | MP0002736_abnormal_nociception_after | 0.66220180 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Decreased circulating renin level (HP:0003351) | 4.68056002 |
| 2 | Hypoglycemic seizures (HP:0002173) | 4.14759200 |
| 3 | Hypothermia (HP:0002045) | 4.02761902 |
| 4 | Hyperactive renin-angiotensin system (HP:0000841) | 3.84126386 |
| 5 | Symptomatic seizures (HP:0011145) | 3.82166173 |
| 6 | Elevated circulating parathyroid hormone (PTH) level (HP:0003165) | 3.80727820 |
| 7 | Abnormality of calcium-phosphate metabolism (HP:0100530) | 3.78285550 |
| 8 | Congenital sensorineural hearing impairment (HP:0008527) | 3.68656638 |
| 9 | Pancreatic fibrosis (HP:0100732) | 3.63093093 |
| 10 | Unilateral renal agenesis (HP:0000122) | 3.62073672 |
| 11 | Febrile seizures (HP:0002373) | 3.61439389 |
| 12 | Ventricular fibrillation (HP:0001663) | 3.60961284 |
| 13 | Stomatitis (HP:0010280) | 3.59527700 |
| 14 | Abnormality of glycolipid metabolism (HP:0010969) | 3.55235689 |
| 15 | Abnormality of liposaccharide metabolism (HP:0010968) | 3.55235689 |
| 16 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 3.55235689 |
| 17 | Absent eyebrow (HP:0002223) | 3.52649244 |
| 18 | True hermaphroditism (HP:0010459) | 3.44338443 |
| 19 | Recurrent cutaneous fungal infections (HP:0011370) | 3.37769244 |
| 20 | Chronic mucocutaneous candidiasis (HP:0002728) | 3.37769244 |
| 21 | Osteomalacia (HP:0002749) | 3.26594943 |
| 22 | Vacuolated lymphocytes (HP:0001922) | 3.16706218 |
| 23 | Cystic liver disease (HP:0006706) | 3.11436422 |
| 24 | Abnormality of dental color (HP:0011073) | 3.09771908 |
| 25 | Aplasia/Hypoplasia of the fovea (HP:0008060) | 3.03461620 |
| 26 | Hypoplasia of the fovea (HP:0007750) | 3.03461620 |
| 27 | Hyperphosphatemia (HP:0002905) | 3.01864835 |
| 28 | Hematochezia (HP:0002573) | 2.99770271 |
| 29 | Progressive inability to walk (HP:0002505) | 2.98658376 |
| 30 | Progressive sensorineural hearing impairment (HP:0000408) | 2.97869559 |
| 31 | Recurrent bacterial skin infections (HP:0005406) | 2.96119363 |
| 32 | Hyperglycemia (HP:0003074) | 2.96068132 |
| 33 | Hyperinsulinemic hypoglycemia (HP:0000825) | 2.95839236 |
| 34 | Abnormality of the columella (HP:0009929) | 2.94244192 |
| 35 | Chronic hepatic failure (HP:0100626) | 2.93129458 |
| 36 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 2.92613313 |
| 37 | Insulin-resistant diabetes mellitus (HP:0000831) | 2.92268972 |
| 38 | Prolonged QT interval (HP:0001657) | 2.91812503 |
| 39 | Abnormality of renin-angiotensin system (HP:0000847) | 2.91790312 |
| 40 | Molar tooth sign on MRI (HP:0002419) | 2.90270412 |
| 41 | Abnormality of midbrain morphology (HP:0002418) | 2.90270412 |
| 42 | Recurrent fungal infections (HP:0002841) | 2.88279438 |
| 43 | Increased cerebral lipofuscin (HP:0011813) | 2.88255598 |
| 44 | Submucous cleft hard palate (HP:0000176) | 2.86492008 |
| 45 | Mutism (HP:0002300) | 2.83940069 |
| 46 | Pancreatic cysts (HP:0001737) | 2.83724422 |
| 47 | Bifid tongue (HP:0010297) | 2.80066289 |
| 48 | Global brain atrophy (HP:0002283) | 2.79612615 |
| 49 | Chromosomal breakage induced by crosslinking agents (HP:0003221) | 2.78421997 |
| 50 | Focal motor seizures (HP:0011153) | 2.78162595 |
| 51 | Hyperkalemia (HP:0002153) | 2.75568973 |
| 52 | Conjugated hyperbilirubinemia (HP:0002908) | 2.72563933 |
| 53 | Optic neuritis (HP:0100653) | 2.71010476 |
| 54 | Retrobulbar optic neuritis (HP:0100654) | 2.71010476 |
| 55 | Abnormality of macrophages (HP:0004311) | 2.68706880 |
| 56 | Autoimmune thrombocytopenia (HP:0001973) | 2.68368550 |
| 57 | Hyperaldosteronism (HP:0000859) | 2.67264837 |
| 58 | Supranuclear gaze palsy (HP:0000605) | 2.66579768 |
| 59 | Focal seizures (HP:0007359) | 2.63906750 |
| 60 | Postural instability (HP:0002172) | 2.63455676 |
| 61 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 2.63242466 |
| 62 | Inability to walk (HP:0002540) | 2.62627964 |
| 63 | Recurrent abscess formation (HP:0002722) | 2.62310326 |
| 64 | Abnormality of the fovea (HP:0000493) | 2.61854483 |
| 65 | Hypokalemia (HP:0002900) | 2.51257697 |
| 66 | Abnormal EKG (HP:0003115) | 2.46418661 |
| 67 | Keratoconjunctivitis (HP:0001096) | 2.43896883 |
| 68 | Recurrent skin infections (HP:0001581) | 2.39972976 |
| 69 | Chromsome breakage (HP:0040012) | 2.37641845 |
| 70 | Clumsiness (HP:0002312) | 2.36556509 |
| 71 | Myositis (HP:0100614) | 2.34913080 |
| 72 | Absent speech (HP:0001344) | 2.34345822 |
| 73 | Abnormal hair whorl (HP:0010721) | 2.33940440 |
| 74 | Abnormality of chloride homeostasis (HP:0011422) | 2.33127425 |
| 75 | Panhypogammaglobulinemia (HP:0003139) | 2.32625680 |
| 76 | Dynein arm defect of respiratory motile cilia (HP:0012255) | 2.32322738 |
| 77 | Absent/shortened dynein arms (HP:0200106) | 2.32322738 |
| 78 | Widely spaced teeth (HP:0000687) | 2.31774428 |
| 79 | Increased CSF protein (HP:0002922) | 2.31374118 |
| 80 | Cheilitis (HP:0100825) | 2.29726469 |
| 81 | Orchitis (HP:0100796) | 2.29074493 |
| 82 | Chronic bronchitis (HP:0004469) | 2.28278795 |
| 83 | Abnormal sex determination (HP:0012244) | 2.25698926 |
| 84 | Sex reversal (HP:0012245) | 2.25698926 |
| 85 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 2.24616411 |
| 86 | Abnormality of polysaccharide metabolism (HP:0011012) | 2.24616411 |
| 87 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 2.24616411 |
| 88 | Abnormality of potassium homeostasis (HP:0011042) | 2.23696211 |
| 89 | Renal cortical cysts (HP:0000803) | 2.21758921 |
| 90 | Aplasia/Hypoplasia of the tongue (HP:0010295) | 2.21703411 |
| 91 | Eosinophilia (HP:0001880) | 2.20519103 |
| 92 | Volvulus (HP:0002580) | 2.16787580 |
| 93 | Abnormal biliary tract physiology (HP:0012439) | 2.16030595 |
| 94 | Bile duct proliferation (HP:0001408) | 2.16030595 |
| 95 | Syncope (HP:0001279) | 2.15907827 |
| 96 | Intestinal atresia (HP:0011100) | 2.15657613 |
| 97 | Dialeptic seizures (HP:0011146) | 2.15608146 |
| 98 | Absent eyelashes (HP:0000561) | 2.14271324 |
| 99 | Encephalitis (HP:0002383) | 2.14205662 |
| 100 | Agitation (HP:0000713) | 2.12562295 |
| 101 | Thyroiditis (HP:0100646) | 2.11434930 |
| 102 | Testicular neoplasm (HP:0010788) | 2.07730913 |
| 103 | Petechiae (HP:0000967) | 2.07639666 |
| 104 | Generalized hypopigmentation of hair (HP:0011358) | 2.07119633 |
| 105 | Intellectual disability, progressive (HP:0006887) | 2.06995274 |
| 106 | Abnormal rod and cone electroretinograms (HP:0008323) | 2.06329135 |
| 107 | Absent rod-and cone-mediated responses on ERG (HP:0007688) | 2.06247998 |
| 108 | Medial flaring of the eyebrow (HP:0010747) | 2.05500587 |
| 109 | Abnormal ciliary motility (HP:0012262) | 2.05460411 |
| 110 | Bradycardia (HP:0001662) | 2.05029834 |
| 111 | Prolonged neonatal jaundice (HP:0006579) | 2.04888131 |
| 112 | Abnormality of binocular vision (HP:0011514) | 2.04440536 |
| 113 | Diplopia (HP:0000651) | 2.04440536 |
| 114 | Progressive hearing impairment (HP:0001730) | 2.04200481 |
| 115 | Urinary glycosaminoglycan excretion (HP:0003541) | 2.02839754 |
| 116 | Mucopolysacchariduria (HP:0008155) | 2.02839754 |
| 117 | Meningitis (HP:0001287) | 2.02805158 |
| 118 | Inflammation of the large intestine (HP:0002037) | 2.02399899 |
| 119 | Tubulointerstitial nephritis (HP:0001970) | 2.02136142 |
| 120 | Occipital encephalocele (HP:0002085) | 1.99166322 |
| 121 | Agammaglobulinemia (HP:0004432) | 1.99066660 |
| 122 | Atonic seizures (HP:0010819) | 1.98318337 |
| 123 | Median cleft lip (HP:0000161) | 1.98154836 |
| 124 | Eczematoid dermatitis (HP:0000976) | 1.97896602 |
| 125 | Delusions (HP:0000746) | 1.97608007 |
| 126 | Alveolar cell carcinoma (HP:0006519) | 1.97408838 |
| 127 | Tetany (HP:0001281) | 1.97380964 |
| 128 | Granulocytopenia (HP:0001913) | 1.97082034 |
| 129 | Generalized tonic-clonic seizures (HP:0002069) | 1.96456420 |
| 130 | Visual hallucinations (HP:0002367) | 1.96129814 |
| 131 | Nephrogenic diabetes insipidus (HP:0009806) | 1.96096645 |
| 132 | Absence seizures (HP:0002121) | 1.95883937 |
| 133 | Keratoconjunctivitis sicca (HP:0001097) | 1.95433665 |
| 134 | Abnormality of eosinophils (HP:0001879) | 1.93950841 |
| 135 | Vasculitis (HP:0002633) | 1.92107475 |
| 136 | Nephronophthisis (HP:0000090) | 1.91267611 |
| 137 | Abnormal respiratory motile cilium physiology (HP:0012261) | 1.90121259 |
| 138 | Recurrent viral infections (HP:0004429) | 1.90098225 |
| 139 | Hypocalcemia (HP:0002901) | 1.89343418 |
| 140 | Oligohydramnios (HP:0001562) | 1.89023840 |
| 141 | Generalized myoclonic seizures (HP:0002123) | 1.88852063 |
| 142 | Hemiparesis (HP:0001269) | 1.88037280 |
| 143 | Abnormality of B cell number (HP:0010975) | 1.86941772 |
| 144 | Abnormality of the renal medulla (HP:0100957) | 1.86120453 |
| 145 | Gaze-evoked nystagmus (HP:0000640) | 1.85685901 |
| 146 | Septo-optic dysplasia (HP:0100842) | 1.85531047 |
| 147 | Neoplasm of the tracheobronchial system (HP:0100552) | 1.84776012 |
| 148 | Blue irides (HP:0000635) | 1.83964504 |
| 149 | Abnormality of the right ventricle (HP:0001707) | 1.83492139 |
| 150 | Recurrent gram-negative bacterial infections (HP:0005420) | 1.82837580 |
| 151 | Follicular hyperkeratosis (HP:0007502) | 1.82420672 |
| 152 | Leukocytosis (HP:0001974) | 1.81926083 |
| 153 | Attenuation of retinal blood vessels (HP:0007843) | 1.81915933 |
| 154 | Dyschromatopsia (HP:0007641) | 1.81879745 |
| 155 | Thoracic kyphosis (HP:0002942) | 1.81825930 |
| 156 | Large for gestational age (HP:0001520) | 1.80896164 |
| 157 | Congenital hepatic fibrosis (HP:0002612) | 1.79284345 |
| 158 | Progressive cerebellar ataxia (HP:0002073) | 1.78846393 |
| 159 | Abnormality of the lumbar spine (HP:0100712) | 1.76704922 |
| 160 | Pulmonary infiltrates (HP:0002113) | 1.76400586 |
| 161 | Patchy hypopigmentation of hair (HP:0011365) | 1.75397715 |
| 162 | Dysostosis multiplex (HP:0000943) | 1.75327820 |
| 163 | Aplasia/Hypoplasia of the lens (HP:0008063) | 1.74124001 |
| 164 | Epileptic encephalopathy (HP:0200134) | 1.73698533 |
| 165 | Respiratory insufficiency due to defective ciliary clearance (HP:0200073) | 1.72999316 |
| 166 | Abnormality of the renal collecting system (HP:0004742) | 1.72381813 |
| 167 | Low anterior hairline (HP:0000294) | 1.71871214 |
| 168 | Hypoplastic iliac wings (HP:0002866) | 1.71790946 |
| 169 | Aganglionic megacolon (HP:0002251) | 1.71757478 |
| 170 | Gonadal dysgenesis (HP:0000133) | 1.71735450 |
| 171 | Gastrointestinal inflammation (HP:0004386) | 1.71393858 |
| 172 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 1.71343857 |
| 173 | Nephropathy (HP:0000112) | 1.71163980 |
| 174 | Renal dysplasia (HP:0000110) | 1.71114585 |
| 175 | Prominent metopic ridge (HP:0005487) | 1.70188956 |
| 176 | Optic nerve hypoplasia (HP:0000609) | 1.70179299 |
| 177 | Postaxial foot polydactyly (HP:0001830) | 1.70060205 |
| 178 | IgG deficiency (HP:0004315) | 1.69979884 |
| 179 | Colitis (HP:0002583) | 1.69265980 |
| 180 | Truncal ataxia (HP:0002078) | 1.68706579 |
| 181 | Congenital primary aphakia (HP:0007707) | 1.68649710 |
| 182 | Lymphopenia (HP:0001888) | 1.68497309 |
| 183 | Lip pit (HP:0100267) | 1.68454339 |
| 184 | Aplasia/Hypoplasia of the uvula (HP:0010293) | 1.67257269 |
| 185 | Abnormality of incisor morphology (HP:0011063) | 1.66891382 |
| 186 | Prostate neoplasm (HP:0100787) | 1.66643559 |
| 187 | Gait imbalance (HP:0002141) | 1.64866881 |
| 188 | Hyponatremia (HP:0002902) | 1.64347033 |
| 189 | Parakeratosis (HP:0001036) | 1.64316573 |
| 190 | Optic nerve coloboma (HP:0000588) | 1.63932089 |
| 191 | Protruding tongue (HP:0010808) | 1.63377314 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MAP3K9 | 4.43442355 |
| 2 | SIK3 | 4.33622204 |
| 3 | IRAK4 | 4.10387357 |
| 4 | INSRR | 3.96136577 |
| 5 | IRAK3 | 3.82972261 |
| 6 | TNIK | 3.05472134 |
| 7 | RIPK4 | 3.03215973 |
| 8 | AKT3 | 2.61530779 |
| 9 | CASK | 2.60131805 |
| 10 | NTRK3 | 2.42134734 |
| 11 | TAOK3 | 2.26687385 |
| 12 | BMPR2 | 2.08351284 |
| 13 | IRAK2 | 1.97836799 |
| 14 | SIK2 | 1.87579644 |
| 15 | ZAK | 1.81266819 |
| 16 | MAP2K7 | 1.81092847 |
| 17 | BMPR1B | 1.73089531 |
| 18 | MAPK13 | 1.69350861 |
| 19 | SGK2 | 1.66647507 |
| 20 | CDK8 | 1.63770627 |
| 21 | MAP2K3 | 1.62694124 |
| 22 | ADRBK2 | 1.55254355 |
| 23 | PRPF4B | 1.53926825 |
| 24 | LATS1 | 1.53274707 |
| 25 | MAP4K1 | 1.51949981 |
| 26 | PASK | 1.51621314 |
| 27 | IRAK1 | 1.48087794 |
| 28 | DAPK2 | 1.45925910 |
| 29 | FES | 1.42327440 |
| 30 | BLK | 1.42182169 |
| 31 | TAOK1 | 1.39552592 |
| 32 | FRK | 1.39275794 |
| 33 | MAPK15 | 1.32756835 |
| 34 | JAK1 | 1.25939472 |
| 35 | HIPK2 | 1.22486322 |
| 36 | BRAF | 1.20870686 |
| 37 | WNK3 | 1.19743890 |
| 38 | BTK | 1.19205147 |
| 39 | MAP3K13 | 1.17150613 |
| 40 | MAPK12 | 1.16841352 |
| 41 | MAP3K2 | 1.15599433 |
| 42 | ERBB3 | 1.14712671 |
| 43 | SYK | 1.12434555 |
| 44 | MAP3K5 | 1.12280479 |
| 45 | CDK3 | 1.11392659 |
| 46 | CAMKK1 | 1.10369903 |
| 47 | YES1 | 1.09169436 |
| 48 | PAK3 | 1.09084424 |
| 49 | MAP2K6 | 1.08636194 |
| 50 | MUSK | 1.08187381 |
| 51 | SIK1 | 1.08103980 |
| 52 | MAP3K14 | 1.06518001 |
| 53 | MAPKAPK3 | 1.05165985 |
| 54 | SGK223 | 1.03327457 |
| 55 | SGK494 | 1.03327457 |
| 56 | TXK | 1.01659098 |
| 57 | CSNK1G2 | 1.00050160 |
| 58 | MAP2K4 | 0.99710192 |
| 59 | GRK7 | 0.98407152 |
| 60 | KSR2 | 0.98367741 |
| 61 | CSNK1A1L | 0.97959708 |
| 62 | CSK | 0.97357383 |
| 63 | MAP3K6 | 0.96279429 |
| 64 | TGFBR2 | 0.94667891 |
| 65 | PRKD3 | 0.94405712 |
| 66 | RPS6KA2 | 0.93946935 |
| 67 | MATK | 0.93659820 |
| 68 | CSNK1G3 | 0.93505650 |
| 69 | STK38L | 0.92883741 |
| 70 | TRPM7 | 0.91432206 |
| 71 | IKBKE | 0.89251198 |
| 72 | PDK1 | 0.88413229 |
| 73 | NEK6 | 0.87942184 |
| 74 | PINK1 | 0.87320526 |
| 75 | SGK3 | 0.85409924 |
| 76 | TYK2 | 0.84336707 |
| 77 | PRKCQ | 0.83665890 |
| 78 | JAK2 | 0.78970242 |
| 79 | NUAK1 | 0.78564838 |
| 80 | FGFR3 | 0.77483457 |
| 81 | MAP3K4 | 0.77213748 |
| 82 | MAP3K12 | 0.76024774 |
| 83 | MKNK2 | 0.75660599 |
| 84 | ZAP70 | 0.75522334 |
| 85 | FGR | 0.74686596 |
| 86 | CAMKK2 | 0.74501101 |
| 87 | PRKCE | 0.73882513 |
| 88 | CAMK4 | 0.73669781 |
| 89 | SRPK1 | 0.73175574 |
| 90 | TEC | 0.73166650 |
| 91 | VRK1 | 0.72397933 |
| 92 | CDC42BPA | 0.71521842 |
| 93 | BRD4 | 0.68689958 |
| 94 | KIT | 0.68529060 |
| 95 | MAP3K1 | 0.67569159 |
| 96 | EIF2AK2 | 0.65750578 |
| 97 | STK11 | 0.64461555 |
| 98 | HCK | 0.63580634 |
| 99 | PDPK1 | 0.63496908 |
| 100 | PKN1 | 0.63444210 |
| 101 | UHMK1 | 0.61444806 |
| 102 | ITK | 0.61346950 |
| 103 | MARK3 | 0.60518820 |
| 104 | MARK2 | 0.60425080 |
| 105 | ADRBK1 | 0.60200669 |
| 106 | TNK2 | 0.59787487 |
| 107 | PRKG2 | 0.59027368 |
| 108 | MAPKAPK5 | 0.58740785 |
| 109 | EEF2K | 0.57355538 |
| 110 | PRKCH | 0.56751087 |
| 111 | MOS | 0.56155123 |
| 112 | RPS6KB1 | 0.55716553 |
| 113 | CDK12 | 0.55145970 |
| 114 | BCR | 0.54114913 |
| 115 | SGK1 | 0.51923698 |
| 116 | PAK6 | 0.51608124 |
| 117 | LYN | 0.51197842 |
| 118 | RET | 0.50627542 |
| 119 | CAMK1 | 0.50407756 |
| 120 | NTRK2 | 0.50275651 |
| 121 | NLK | 0.49953881 |
| 122 | PTK2B | 0.49823029 |
| 123 | ALK | 0.49075365 |
| 124 | CDK5 | 0.48982412 |
| 125 | PLK2 | 0.48705117 |
| 126 | TBK1 | 0.48399529 |
| 127 | MYLK | 0.46847220 |
| 128 | EIF2AK3 | 0.46736422 |
| 129 | MINK1 | 0.46609783 |
| 130 | CSNK1G1 | 0.46460018 |
| 131 | GRK1 | 0.45903334 |
| 132 | PRKG1 | 0.45811958 |
| 133 | EPHA3 | 0.43750876 |
| 134 | STK38 | 0.42573895 |
| 135 | PHKG1 | 0.42525500 |
| 136 | PHKG2 | 0.42525500 |
| 137 | CHUK | 0.42226983 |
| 138 | CAMK2A | 0.41220346 |
| 139 | DYRK1A | 0.41054231 |
| 140 | EPHA4 | 0.40801149 |
| 141 | PRKD2 | 0.40734632 |
| 142 | PLK4 | 0.40122517 |
| 143 | WNK1 | 0.39335816 |
| 144 | MARK1 | 0.38594663 |
| 145 | EPHA2 | 0.37649010 |
| 146 | MELK | 0.37423802 |
| 147 | PRKAA1 | 0.37121853 |
| 148 | RPS6KL1 | 0.36983866 |
| 149 | RPS6KC1 | 0.36983866 |
| 150 | TAOK2 | 0.35763116 |
| 151 | AKT1 | 0.34964955 |
| 152 | IKBKB | 0.34092156 |
| 153 | CSNK1A1 | 0.33775634 |
| 154 | ERBB4 | 0.33093524 |
| 155 | PIK3CG | 0.32334888 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 5.51474719 |
| 2 | Protein export_Homo sapiens_hsa03060 | 3.39658971 |
| 3 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 3.02605019 |
| 4 | Insulin secretion_Homo sapiens_hsa04911 | 2.71635055 |
| 5 | Nicotine addiction_Homo sapiens_hsa05033 | 2.64813149 |
| 6 | Taste transduction_Homo sapiens_hsa04742 | 2.31763158 |
| 7 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 2.02926721 |
| 8 | Osteoclast differentiation_Homo sapiens_hsa04380 | 1.92815765 |
| 9 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 1.91400855 |
| 10 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 1.90625736 |
| 11 | Morphine addiction_Homo sapiens_hsa05032 | 1.90319981 |
| 12 | Serotonergic synapse_Homo sapiens_hsa04726 | 1.80551606 |
| 13 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 1.77519729 |
| 14 | Primary immunodeficiency_Homo sapiens_hsa05340 | 1.75886603 |
| 15 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 1.72352586 |
| 16 | Circadian rhythm_Homo sapiens_hsa04710 | 1.71791057 |
| 17 | Allograft rejection_Homo sapiens_hsa05330 | 1.66381450 |
| 18 | Tuberculosis_Homo sapiens_hsa05152 | 1.61021178 |
| 19 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 1.59764618 |
| 20 | Cocaine addiction_Homo sapiens_hsa05030 | 1.58547667 |
| 21 | GABAergic synapse_Homo sapiens_hsa04727 | 1.57181902 |
| 22 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 1.55834962 |
| 23 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 1.53421334 |
| 24 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 1.52576032 |
| 25 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 1.44546170 |
| 26 | Circadian entrainment_Homo sapiens_hsa04713 | 1.43453641 |
| 27 | Amphetamine addiction_Homo sapiens_hsa05031 | 1.36794407 |
| 28 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 1.32913624 |
| 29 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.30606345 |
| 30 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 1.26862090 |
| 31 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 1.25915170 |
| 32 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 1.22874174 |
| 33 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 1.22101399 |
| 34 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 1.20078336 |
| 35 | Glutamatergic synapse_Homo sapiens_hsa04724 | 1.15428019 |
| 36 | Asthma_Homo sapiens_hsa05310 | 1.15243491 |
| 37 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 1.15052446 |
| 38 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 1.14865487 |
| 39 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.13860499 |
| 40 | Cholinergic synapse_Homo sapiens_hsa04725 | 1.12722481 |
| 41 | Other glycan degradation_Homo sapiens_hsa00511 | 1.12534648 |
| 42 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 1.11173668 |
| 43 | Legionellosis_Homo sapiens_hsa05134 | 1.10109947 |
| 44 | Olfactory transduction_Homo sapiens_hsa04740 | 1.09507478 |
| 45 | Regulation of autophagy_Homo sapiens_hsa04140 | 1.08125387 |
| 46 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 1.07440946 |
| 47 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 1.06373682 |
| 48 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 1.03127579 |
| 49 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 1.03082003 |
| 50 | Butanoate metabolism_Homo sapiens_hsa00650 | 1.02592251 |
| 51 | Malaria_Homo sapiens_hsa05144 | 0.99768510 |
| 52 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 0.99010773 |
| 53 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.95625990 |
| 54 | Dopaminergic synapse_Homo sapiens_hsa04728 | 0.94459864 |
| 55 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.93868223 |
| 56 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.90393364 |
| 57 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 0.88854533 |
| 58 | Calcium signaling pathway_Homo sapiens_hsa04020 | 0.88828255 |
| 59 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.88269752 |
| 60 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.87812999 |
| 61 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.85976017 |
| 62 | Renin secretion_Homo sapiens_hsa04924 | 0.83682450 |
| 63 | Long-term potentiation_Homo sapiens_hsa04720 | 0.83607479 |
| 64 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 0.80041853 |
| 65 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.79389533 |
| 66 | Mineral absorption_Homo sapiens_hsa04978 | 0.78297668 |
| 67 | Long-term depression_Homo sapiens_hsa04730 | 0.78105007 |
| 68 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 0.77797102 |
| 69 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.76178992 |
| 70 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.76144371 |
| 71 | Hepatitis B_Homo sapiens_hsa05161 | 0.73375370 |
| 72 | cAMP signaling pathway_Homo sapiens_hsa04024 | 0.72599924 |
| 73 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.71446804 |
| 74 | Influenza A_Homo sapiens_hsa05164 | 0.69670641 |
| 75 | Measles_Homo sapiens_hsa05162 | 0.68974428 |
| 76 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.67685293 |
| 77 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 0.67614534 |
| 78 | Platelet activation_Homo sapiens_hsa04611 | 0.67392230 |
| 79 | Herpes simplex infection_Homo sapiens_hsa05168 | 0.66104898 |
| 80 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 0.66086615 |
| 81 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.65552462 |
| 82 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.64359448 |
| 83 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.63221996 |
| 84 | Antigen processing and presentation_Homo sapiens_hsa04612 | 0.61569351 |
| 85 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 0.60611539 |
| 86 | Salivary secretion_Homo sapiens_hsa04970 | 0.60591658 |
| 87 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.59972159 |
| 88 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.59231589 |
| 89 | Gap junction_Homo sapiens_hsa04540 | 0.59015901 |
| 90 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.58119221 |
| 91 | Phototransduction_Homo sapiens_hsa04744 | 0.56059070 |
| 92 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 0.56033759 |
| 93 | Melanoma_Homo sapiens_hsa05218 | 0.55025790 |
| 94 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.55011851 |
| 95 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 0.54210579 |
| 96 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.51011548 |
| 97 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 0.50621054 |
| 98 | Lysosome_Homo sapiens_hsa04142 | 0.50520304 |
| 99 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.50415892 |
| 100 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.50174451 |
| 101 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.49475873 |
| 102 | ABC transporters_Homo sapiens_hsa02010 | 0.47522049 |
| 103 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.47408150 |
| 104 | Graft-versus-host disease_Homo sapiens_hsa05332 | 0.47363646 |
| 105 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 0.47139803 |
| 106 | Phagosome_Homo sapiens_hsa04145 | 0.47043329 |
| 107 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.46407402 |
| 108 | Pertussis_Homo sapiens_hsa05133 | 0.44965107 |
| 109 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.43891821 |
| 110 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 0.43867046 |
| 111 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.43678586 |
| 112 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 0.43309287 |
| 113 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.42796628 |
| 114 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.42478391 |
| 115 | Basal transcription factors_Homo sapiens_hsa03022 | 0.42423027 |
| 116 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.41707399 |
| 117 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 0.39294512 |
| 118 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.39011044 |
| 119 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.38812491 |
| 120 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.37626331 |
| 121 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.37124060 |
| 122 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 0.36171932 |
| 123 | Wnt signaling pathway_Homo sapiens_hsa04310 | 0.35137865 |
| 124 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.34443432 |
| 125 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.34242463 |
| 126 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.33878422 |
| 127 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.33760290 |
| 128 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 0.33700039 |
| 129 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.33306988 |
| 130 | Gastric acid secretion_Homo sapiens_hsa04971 | 0.33204279 |
| 131 | Leishmaniasis_Homo sapiens_hsa05140 | 0.31718948 |
| 132 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.30922865 |

